home / stock / qgen / qgen news

QGEN News and Press, Qiagen N.V. From 06/11/24

Stock Information
Company Name: Qiagen N.V.
Stock Symbol: QGEN
Market: NYSE
Website: qiagen.com
Menu
QGEN QGEN Quote QGEN Short QGEN News QGEN Articles QGEN Message Board
Get QGEN Alerts

News, Short Squeeze, Breakout and More Instantly...
QGEN - QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillance

Venlo, the Netherlands, June 11, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of 35 new wet-lab tested digital PCR Microbial DNA Detection Assays for its digital PCR (dPCR) platform QIAcuity, significantly enhancing its offerings in the fi...
QGEN - QIAGEN to discontinue NeuMoDx, updates 2024 forecast

2024-06-06 17:45:07 ET More on Qiagen Qiagen N.V. 2024 Q1 - Results - Earnings Call Presentation Qiagen N.V. (QGEN) Q1 2024 Earnings Call Transcript QIAGEN gets FDA clearance for QIAstat-Dx Respiratory Panel Plus QIAGEN to collaborate with FBI on forensic PCR...

QGEN - QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition period

Venlo, the Netherlands, June 06, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a decision to discontinue the NeuMoDx 96 and 288 Molecular Systems in light of the market development trends for these product lines following the COVID-19 pandemic and cha...

QGEN - QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of its research platform GeneGlobe

Venlo, the Netherlands, June 05, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of its new digital PCR (dPCR) Custom Assay Design Tool for copy number variation (CNV) analysis for use on its digital PCR platform QIAcuity and several other en...
QGEN - QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improve gastrointestinal care

Germantown, Maryland, and Venlo, the Netherlands, June 03, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAstat-Dx Gastrointestinal Panel 2 in the United States. The launch comes after the recent clearance of the syndromic test for ...

QGEN - QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications

Venlo, the Netherlands, and Salt Lake City, Utah, May 30, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Myriad Genetics (NASDAQ: MYGN) today announced they will develop a globally distributable kit-based test for analyzing Homologous Recombination Deficiency (HRD...

QGEN - QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicine

Venlo, the Netherlands, May 29, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of its QIAseq Multimodal DNA/RNA Lib Kit. The new kit enables seamless preparation of DNA and RNA libraries for next-generation sequencing (NGS), such as whole ge...
QGEN - Lab Instrument Industry Update - New Commercial Entrants

2024-05-23 09:17:40 ET Summary Lab Instrument and Services providers in the healthcare industry can generate high recurring revenues. Many loss-making instrument makers in the industry may not provide meaningful returns and carry high risks. Cytek stands out as the best opport...

QGEN - QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support

Venlo, the Netherlands, May 14, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced an updated version of its clinical decision support platform, QIAGEN Clinical Insight Interpret for NGS molecular profiling of hereditary and somatic diseases, has received ...

QGEN - QIAGEN gets FDA clearance for QIAstat-Dx Respiratory Panel Plus

2024-05-13 14:06:05 ET More on Qiagen Qiagen N.V. 2024 Q1 - Results - Earnings Call Presentation Qiagen N.V. (QGEN) Q1 2024 Earnings Call Transcript QIAGEN to collaborate with FBI on forensic PCR test Qiagen Non-GAAP EPS of $0.46 beats by $0.02, revenue of $4...
Previous 10 Next 10